Becky Jones, a 33-year-old mother of two from Coventry, is leading a group of more than 40 patients taking legal action against University Hospitals Coventry and Warwickshire (UHCW) NHS Trust after receiving a terminal brain tumor diagnosis and subsequent chemotherapy for a condition she never had, according to reports from the BBC.
The misdiagnosis, delivered by consultant professor Ian Brown at University Hospital, Coventry, subjected Jones to 11 years of unnecessary chemotherapy using the drug temozolomide (TMZ). According to BBC reporting, Jones was just 21 years old in 2012 when she was told she had a terminal glioblastoma and months to live, despite guidelines recommending only six cycles over six months.
Decade of Unnecessary Treatment and Side Effects
Jones endured continuous treatment that severely restricted her daily life, career aspirations in policing, and family events. According to the BBC, she experienced constant nausea, stomach pains, mouth ulcers, and chronic fatigue. The rigorous regimen forced her to avoid social gatherings due to infection fears, altered her driving privileges, and led to assertions from her doctor that she would be unable to have children. She later had two children, whom she described to the BBC as miracles.
The ordeal came to a sudden halt in 2024 when Jones received a phone call informing her that her chemotherapy was stopping because Brown had retired. In May 2025, independent analysis by neurosurgeons and radiologists arranged by her legal representatives at Brabners revealed she had never suffered from brain cancer. Instead, she had a tumefactive demyelination—an inflammatory condition typically managed by neurologists using strong steroids rather than long-term chemotherapy.
Legal Action and Institutional Review
Fiona Tinsley, a partner at Brabners representing Jones and other affected patients, described the emotional discovery on a video call with solicitors and medical experts, telling the BBC that “there were just tears in everyone’s eyes.” More than 40 patients are now pursuing legal claims against the trust regarding prolonged or unnecessary cancer treatments.
Preliminary findings from a review by the Royal College of Physicians (RCP), cited by the BBC, indicated that patients at the hospital routinely received prolonged courses of TMZ with little or no evidence of benefit. The review characterized staff failings as a betrayal of patient trust and questioned why oncology pharmacy teams did not challenge patients receiving oral chemotherapy continuously for 10 to 15 years.
In response to the mounting legal challenges and inquiries, UHCW NHS Trust stated it would not comment on individual cases but confirmed that new measures have been implemented to ensure more robust oversight regarding the prescription and administration of TMZ.